Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.72M | 9.05M | 9.81M | 9.95M | 9.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.72M | 9.05M | 9.81M | 9.95M | 9.71M |
| Cost of Revenue | 3.44M | 3.78M | 4.21M | 4.36M | 4.17M |
| Gross Profit | 5.28M | 5.26M | 5.60M | 5.60M | 5.54M |
| SG&A Expenses | 2.12M | 2.23M | 2.44M | 1.98M | 1.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.72M | 6.23M | 6.81M | 6.48M | 6.24M |
| Operating Income | 3.01M | 2.82M | 3.00M | 3.48M | 3.47M |
| Income Before Tax | 3.18M | 3.11M | 3.31M | 3.84M | 3.86M |
| Income Tax Expenses | 578.00K | 540.00K | 678.00K | 788.00K | 817.00K |
| Earnings from Continuing Operations | 2.60M | 2.57M | 2.63M | 3.05M | 3.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.60M | 2.57M | 2.63M | 3.05M | 3.04M |
| EBIT | 3.01M | 2.82M | 3.00M | 3.48M | 3.47M |
| EBITDA | 3.68M | 3.56M | 3.75M | 4.22M | 4.18M |
| EPS Basic | 0.82 | 0.80 | 0.82 | 0.94 | 0.92 |
| Normalized Basic EPS | 0.71 | 0.68 | 0.72 | 0.79 | 0.79 |
| EPS Diluted | 0.82 | 0.80 | 0.82 | 0.94 | 0.92 |
| Normalized Diluted EPS | 0.71 | 0.68 | 0.72 | 0.79 | 0.79 |
| Average Basic Shares Outstanding | 3.19M | 3.20M | 3.21M | 3.25M | 3.31M |
| Average Diluted Shares Outstanding | 3.19M | 3.20M | 3.21M | 3.25M | 3.31M |
| Dividend Per Share | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
| Payout Ratio | 37.98% | 38.07% | 37.55% | 32.84% | 33.44% |